Flamingo Therapeutics
PrivateLast Round
Grant
Jun 15, 2023
Total Funding Raised
$1.85M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Flamingo Therapeutics operates in Healthcare & Life Sciences and is based in Leuven. Its latest recorded funding round was a Grant round in June 2023.
Flamingo Therapeutics is a biotechnology company that develops RNA-targeted therapies for oncology.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Flamingo Therapeutics Comparables
Compare Flamingo Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Amaroq Therapeutics | 87% | |
| Aummune | 82% | |
| HAYA Therapeutics | 81% |
For institutional investors. Book with your work email.
Flamingo Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Jun 15, 2023 | ||||
| Corporate Funding | Mar 2, 2023 | ||||
| VC Round | Jul 1, 2021 |
For institutional investors. Book with your work email.
Flamingo Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| University of Michigan | Series A |
| KU Leuven | Series A |
| VLAIO | Grant |
| PMV | Series A, VC Round, Corporate Funding |
| Ghent University | Series A |
| VIB | Series A |
| Kurma Partners | Series A, VC Round, Corporate Funding |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 20, 2026
Open roles increased from 0 to 6, representing 120% of headcount.
- Jun 1, 2025
Monthly visitors grew 46% MoM, from 751 to 1.1K.
For institutional investors. Book with your work email.
Flamingo Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Flamingo Therapeutics's valuation, stock price, and market status.
Is Flamingo Therapeutics a public or private company?
Flamingo Therapeutics is a private company.
What is the current stock price of Flamingo Therapeutics?
Flamingo Therapeutics is a private company, so its shares have no public market price. Caplight tracks Flamingo Therapeutics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Flamingo Therapeutics worth (valuation)?
Valuation information for Flamingo Therapeutics is not publicly available.
Can I buy Flamingo Therapeutics stock?
Flamingo Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Flamingo Therapeutics's last funding round?
Flamingo Therapeutics's most recent funding round was Grant on June 15, 2023.
Who are the main investors in Flamingo Therapeutics?
Key investors in Flamingo Therapeutics include University of Michigan, KU Leuven, VLAIO, PMV, Ghent University.
Will Flamingo Therapeutics IPO soon?
No public IPO plans have been announced for Flamingo Therapeutics.
How can I track Flamingo Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades in Flamingo Therapeutics's shares on secondary markets.